TY - JOUR T1 - Transmission of SARS-CoV-2 following exposure in school settings: experience from two Helsinki area exposure incidents. JF - medRxiv DO - 10.1101/2020.07.20.20156018 SP - 2020.07.20.20156018 AU - Timothee Dub AU - Elina Erra AU - Lotta Hagberg AU - Emmi Sarvikivi AU - Camilla Virta AU - Asko Järvinen AU - Pamela Österlund AU - Niina Ikonen AU - Anu Haveri AU - Merit Melin AU - Timo Lukkarinen AU - Hanna Nohynek Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/30/2020.07.20.20156018.abstract N2 - Background The role of children in SARS-CoV-2 transmission is unclear. We investigated two COVID-19 school exposure incidents in the Helsinki area.Methods We conducted two retrospective cohort studies after schools exposures, with a household transmission extension. We defined a case as an exposed person with either a positive RT-PCR, or positive microneutralisation testing (MNT) as confirmation of SARS-CoV-2 nucleoprotein IgG antibodies detection via fluorescent microsphere immunoassay (FMIA). We recruited close school contacts and families of school cases, calculated attack rates (AR) on school level and families, and identified transmission chains.Findings In incident A, the index was a pupil. Participation rate was 74% (89/121), and no cases were identified. In incident B, the index was a member of school personnel. Participation rate was 81% (51/63). AR was 16% (8/51): 6 pupils and 1 member of school personnel were MNT and FMIA positive; 1 pupil had a positive RT-PCR, but negative serology samples. We visited all school cases’ families (n=8). The AR among close household contacts was 42% (9/20 in 3/8 families) but other plausible sources were always reported. At three months post-exposure, 6/8 school cases were re-sampled and still MNT positive.Interpretation When the index was a child, no school transmission was identified, while the occurrence of an adult case led to a 16% AR. Further cases were evidenced in 3 families, but other transmission chains were plausible. It is likely that transmission from children to adults is limited.Funding The Finnish Institute for Health and Welfare funded this study.Evidence before the study The first autochthonous case of COVID-19 in Finland was identified on February 29th. Transmission of the virus has led to more than 7250 cases and over 300 deaths (As of July 12th 2020). On March 16th, assuming that children might have a role in transmission, the Finnish government ordered school closures, to the exclusion of pre-school and grades 1-3. Schools were closed from March 18 and reopened on May 14th. At the stage of closure, a very limited number of reports of school related COVID-19 clusters or exposure incidents had been published, and the potential extent of transmission in a school setting was unknown.Added value of this study We investigated two exposure incidents in two different schools from the Helsinki area to assess transmission among pupils, school personnel and household contacts of identified cases. In school A, contact with a COVID-19 pupil did not lead to further transmission, while in school B, out of 51 recruited contacts, eight (16%) were proved to have had COVID-19 infection, including one member of staff. Among the close household contacts of pupils who were tested positive, COVID-19 attack rate was 31% (5/16). However, in all investigated households, other sources of infections were plausible; hence household transmission following a pediatric COVID-19 case appears to be limited.Implications of all of the available evidence Incidence of COVID-19 infections in children following school related exposure was limited, as well as secondary transmission within their household. We hope our findings will help prioritize mitigation measures as well as reduce worry among parents of school aged children as most EU countries are preparing for the start of a new school year in autumn.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Finnish Institute for Health and Welfare funded this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Steering committee of the Infectious Disease Control and Vaccinations of the Department of Health Security (Finnish institute for Health and Welfare) exempted this research from further institutional ethical review. The Finnish communicable diseases law and the law on the duties of the Finnish Institute for Health and Welfare allowed the implementation of this research without seeking further institutional ethical review.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData cannot be transferred or shared ER -